Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
11th May 201710:24 amRNSForm 8.5 (EPT/NON-RI)
3rd May 20179:45 amRNSForm 8.5 (EPT/NON-RI)
2nd May 201710:38 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 201710:09 amRNSForm 8.5 (EPT/NON-RI)
25th Apr 201710:10 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20179:30 amRNSForm 8.5 (EPT/NON-RI)
18th Apr 20177:00 amRNSBlock listing Interim Review
13th Apr 201710:05 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 20175:43 pmRNSDirector/PDMR Shareholding
12th Apr 20175:35 pmRNSDirector/PDMR Shareholding
11th Apr 201710:35 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201710:18 amRNSForm 8.5 (EPT/NON-RI)
7th Apr 20174:10 pmRNSAnnual Report and Notice of AGM
4th Apr 201712:07 pmRNSDirectorate Change
4th Apr 201710:26 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201710:04 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20179:58 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20177:00 amRNSFinal Results
30th Mar 201711:06 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 201710:01 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 201710:43 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:18 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:15 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:29 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:14 amRNSForm 8.3 - BowLeven Plc
17th Mar 201711:16 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201710:51 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 201710:08 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20179:32 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
9th Mar 20179:40 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 201710:14 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 201710:03 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201610:51 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 20169:52 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201611:10 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201612:05 pmRNSForm 8.5 (EPT/NON-RI)
12th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 20169:59 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20169:46 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201610:50 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20169:49 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20169:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20167:00 amRNSDirectorate Change
18th Nov 201612:07 pmRNSForm 8.5 (EPT/NON-RI)
16th Nov 20169:47 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 201610:11 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20169:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.